Common Stock, Shares, Outstanding of Tarsus Pharmaceuticals, Inc. from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Tarsus Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • Tarsus Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 42,553,931, a 11% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Tarsus Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 42,553,931 +4,204,105 +11% 31 Dec 2025 10-K 23 Feb 2026 2025 FY
Q3 2025 42,447,882 +4,251,810 +11% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 42,210,972 +4,180,587 +11% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 41,995,537 +4,246,069 +11% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 38,349,826 +4,138,636 +12% 31 Dec 2024 10-K 23 Feb 2026 2025 FY
Q3 2024 38,196,072 +5,091,985 +15% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 38,030,385 +11,130,813 +41% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 37,749,468 +10,948,956 +41% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 34,211,190 +7,511,190 +28% 31 Dec 2023 10-K 25 Feb 2025 2024 FY
Q3 2023 33,104,087 +6,432,275 +24% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 26,899,572 +255,320 +0.96% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 26,800,512 +6,081,984 +29% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 26,700,000 +6,001,263 +29% 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q3 2022 26,671,812 +6,000,733 +29% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 26,644,252 +6,070,301 +30% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 20,718,528 +194,054 +0.94% 31 Mar 2022 10-Q 11 May 2022 2022 Q1
Q4 2021 20,698,737 +375,536 +1.8% 31 Dec 2021 10-K 17 Mar 2023 2022 FY
Q3 2021 20,671,079 +17,783,091 +616% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 20,573,951 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 20,524,474 31 Mar 2021 10-Q 11 May 2021 2021 Q1
Q4 2020 20,323,201 +17,676,582 +668% 31 Dec 2020 10-K 14 Mar 2022 2021 FY
Q3 2020 2,887,988 30 Sep 2020 10-Q 25 Nov 2020 2020 Q3
Q4 2019 2,646,619 31 Dec 2019 10-K 31 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.